One of your best @otherperspective. And as always, presented in a clear and simple way for many of us laypersons to understand.
If you have time could you very briefly expand on what approximate % differential figure ( control v treatment) of reductions in MACE , you imagine would fit each category?
For eg:
1. Overwhelming efficiency (40%-100%)
2. Confirmation trial required. (15%- 40% )
3. Fail. ( 0-15%)
* I have no idea
Also do you still hold hope for Feb Headline results if permitted?
MSB Trading - 2020, page-297
-
- There are more pages in this discussion • 22,864 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.030(2.29%) |
Mkt cap ! $1.461B | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.28 | $1.677M | 1.289M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 44452 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.29 | 23596 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |